Cargando…

The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis

Systemic sclerosis (SSc) is a connective tissue disease of autoimmune origin characterized by vascular dysfunction and extensive fibrosis of the skin and visceral organs. Vascular dysfunction is caused by endothelial cell (EC) apoptosis, defective angiogenesis, defective vasculogenesis, endothelial-...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kanno, Yosuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387418/ https://www.ncbi.nlm.nih.gov/pubmed/30709025 http://dx.doi.org/10.3390/ijms20030619

Ejemplares similares

Vascular Dysfunction in Alzheimer’s Disease: Alterations in the Plasma Contact and Fibrinolytic Systems
por: Badimon, Ana, et al.
Publicado: (2023)

α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis
por: Kanno, Yosuke, et al.
Publicado: (2017)

The Fibrinolytic System: Mysteries and Opportunities
por: Medcalf, Robert L., et al.
Publicado: (2021)

Therapeutics targeting the fibrinolytic system
por: Lin, Haili, et al.
Publicado: (2020)

The Role of Fibrinolytic System in Health and Disease
por: Kwaan, Hau C.
Publicado: (2022)

Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications
por: Mahmood, Niaz, et al.
Publicado: (2021)

Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation
por: Hu, Yan, et al.
Publicado: (2019)

Regulation of macrophage activation in the liver after acute injury: Role of the fibrinolytic system
por: Roth, Katherine, et al.
Publicado: (2020)

Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
por: Singh, Rajni, et al.
Publicado: (2023)

α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
por: Kanno, Yosuke, et al.
Publicado: (2022)

The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression
por: Kanno, Yosuke
Publicado: (2023)

Standardization of Measurement of Components of the Fibrinolytic System - Introduction and Current Status
por: Gram, Jørgen, et al.
Publicado: (2000)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
por: Kwaan, Hau C., et al.
Publicado: (2021)

Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
por: Altaf, Farwa, et al.
Publicado: (2021)

Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins
por: Wang, Tingyu, et al.
Publicado: (2023)

Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport
por: Fu, Yunmei, et al.
Publicado: (2023)

The Inflammatory Actions of Coagulant and Fibrinolytic Proteases in Disease
por: Schuliga, Michael
Publicado: (2015)

Endothelial Dysfunction in Systemic Sclerosis
por: Patnaik, Eshaan, et al.
Publicado: (2023)

The Role of Clock Genes in Fibrinolysis Regulation: Circadian Disturbance and Its Effect on Fibrinolytic Activity
por: Carmona, Pamela, et al.
Publicado: (2020)

The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment
por: Hvas, Christine Lodberg, et al.
Publicado: (2023)

Changes in the Coagulation and Fibrinolytic System of Patients with Subarachnoid Hemorrhage
por: JI, Yong, et al.
Publicado: (2014)

The Vascular Microenvironment and Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2010)

Fibrinolytic and antibiotic treatment of prosthetic vascular graft infections in a novel rat model
por: Johansen, Mikkel Illemann, et al.
Publicado: (2023)

THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI
por: Tillett, William S., et al.
Publicado: (1933)

Fibrinolytic Therapy in Acute Stroke
por: Millán, Mònica, et al.
Publicado: (2010)

Fibrinolytic Changes in Women with Preeclampsia
por: Godtfredsen, Anne Cathrine, et al.
Publicado: (2022)

Vascular involvement in systemic sclerosis (scleroderma)
por: Pattanaik, Debendra, et al.
Publicado: (2011)

Esophageal Dysfunction in Systemic Sclerosis: An Update
por: Li, Bo, et al.
Publicado: (2021)

Fibrinolytics and Intraventricular Hemorrhage: A Systematic Review and Meta-analysis
por: van Solinge, Thomas S., et al.
Publicado: (2019)

Role of Endothelial to Mesenchymal Transition in the Pathogenesis of the Vascular Alterations in Systemic Sclerosis
por: Jimenez, Sergio A.
Publicado: (2013)

Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer
por: Bentov, Yaakov, et al.
Publicado: (2009)

Interaction of streptococcal plasminogen binding proteins with the host fibrinolytic system
por: Fulde, Marcus, et al.
Publicado: (2013)

All tangled up: interactions of the fibrinolytic and innate immune systems
por: Whyte, Claire S.
Publicado: (2023)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients
por: Narula, Naureen, et al.
Publicado: (2021)

Roles of fibrinolytic factors in the alterations in bone marrow hematopoietic stem/progenitor cells during bone repair
por: Okada, Kiyotaka, et al.
Publicado: (2020)

Regulation and Roles of Urocortins in the Vascular System
por: Kageyama, Kazunori, et al.
Publicado: (2012)

Exploring the Therapeutic Potential of Apigenin in Obesity-Associated Fibrinolytic Dysfunction: Insights From an Animal Study
por: Qadi, Hasan H, et al.
Publicado: (2023)

Fibrinolytic and coagulative activities of Yersinia pestis
por: Korhonen, Timo K., et al.
Publicado: (2013)

Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype
por: Hayakawa, Mineji
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_83ag7oi36g65om73bhqqivj2ih